Diabetes Drug Shows Potential For Treating One Cause Of Chronic Kidney Disease
Tuesday, December 16, 2008 - 09:21
in Health & Medicine
The antidiabetes drug rosiglitazone may have the potential to protect kidney function in patients with a condition called focal segmental glomerulosclerosis, according to a new study. The phase I clinical findings indicate that the drug warrants further study in phase II and phase III trials.